Previous Article | Next Article 
Journal of Virology, November 2000, p. 10514-10522, Vol. 74, No. 22
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Effective Induction of Simian Immunodeficiency Virus-Specific
Systemic and Mucosal Immune Responses in Primates by
Vaccination with Proviral DNA Producing Intact but
Noninfectious Virions
Shainn-Wei
Wang,1
Pamela A.
Kozlowski,1
Gretchen
Schmelz,1
Kelledy
Manson,2
Michael S.
Wyand,2
Rhona
Glickman,3
David
Montefiori,4
Jeffrey D.
Lifson,5
R. Paul
Johnson,3,6
Marian R.
Neutra,1 and
Anna
Aldovini1,*
Department of Medicine, Children's Hospital, and
Department of Pediatrics, Harvard Medical School, Boston,
Massachusetts1; Primedica, Worcester,
Massachusetts2; Duke University, Durham,
North Carolina4; Retroviral Pathogenesis
Laboratory, AIDS Vaccine Program, SAIC Frederick, NCI-FCRDC,
Frederick, Maryland5; New England
Primate Research Center, Harvard Medical School, Southborough,
Massachusetts3; and Partners AIDS
Research Center and Infectious Disease Unit, Massachusetts General
Hospital, Charlestown, Massachusetts6
Received 28 April 2000/Accepted 15 August 2000
We report a pilot evaluation of a DNA vaccine producing genetically
inactivated simian immunodeficiency virus (SIV) particles in primates,
with a focus on eliciting mucosal immunity. Our results demonstrate
that DNA vaccines can be used to stimulate strong virus-specific
mucosal immune responses in primates. The levels of immunoglobulin A
(IgA) detected in rectal secretions of macaques that received the DNA
vaccine intradermally and at the rectal mucosa were the most
striking of all measured immune responses and were higher than usually
achieved through natural infection. However, cytotoxic T lymphocyte
responses were generally low and sporadically present in different
animals. Upon rectal challenge with cloned SIVmac239, resistance to
infection was observed, but some animals with high SIV-specific IgA
levels in rectal secretions became infected. Our results suggest that
high levels of IgA alone are not sufficient to prevent the
establishment of chronic infection, although mucosal IgA responses may
have a role in reducing the infectivity of the initial viral inoculum.
*
Corresponding author. Mailing address: Children's
Hospital, Enders 609, 300 Longwood Ave., Boston, MA 02115. Phone: (617) 355-8426. Fax: (617) 355-8387. E-mail:
anna.aldovini{at}tch.harvard.edu.
Journal of Virology, November 2000, p. 10514-10522, Vol. 74, No. 22
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Letvin, N. L., Rao, S. S., Dang, V., Buzby, A. P., Korioth-Schmitz, B., Dombagoda, D., Parvani, J. G., Clarke, R. H., Bar, L., Carlson, K. R., Kozlowski, P. A., Hirsch, V. M., Mascola, J. R., Nabel, G. J.
(2007). No Evidence for Consistent Virus-Specific Immunity in Simian Immunodeficiency Virus-Exposed, Uninfected Rhesus Monkeys. J. Virol.
81: 12368-12374
[Abstract]
[Full Text]
-
Gupta, S., Leutenegger, C. M., Dean, G. A., Steckbeck, J. D., Cole, K. S., Sparger, E. E.
(2007). Vaccination of Cats with Attenuated Feline Immunodeficiency Virus Proviral DNA Vaccine Expressing Gamma Interferon. J. Virol.
81: 465-473
[Abstract]
[Full Text]
-
Amara, R. R., Patel, K., Niedziela, G., Nigam, P., Sharma, S., Staprans, S. I., Montefiori, D. C., Chenareddi, L., Herndon, J. G., Robinson, H. L., McClure, H. M., Novembre, F. J.
(2005). A Combination DNA and Attenuated Simian Immunodeficiency Virus Vaccine Strategy Provides Enhanced Protection from Simian/Human Immunodeficiency Virus-Induced Disease. J. Virol.
79: 15356-15367
[Abstract]
[Full Text]
-
Yoshino, N., Lu, F. X.-S., Fujihashi, K., Hagiwara, Y., Kataoka, K., Lu, D., Hirst, L., Honda, M., van Ginkel, F. W., Takeda, Y., Miller, C. J., Kiyono, H., McGhee, J. R.
(2004). A Novel Adjuvant for Mucosal Immunity to HIV-1 gp120 in Nonhuman Primates. J. Immunol.
173: 6850-6857
[Abstract]
[Full Text]
-
Bertley, F. M. N., Kozlowski, P. A., Wang, S.-W., Chappelle, J., Patel, J., Sonuyi, O., Mazzara, G., Montefiori, D., Carville, A., Mansfield, K. G., Aldovini, A.
(2004). Control of Simian/Human Immunodeficiency Virus Viremia and Disease Progression after IL-2-Augmented DNA-Modified Vaccinia Virus Ankara Nasal Vaccination in Nonhuman Primates. J. Immunol.
172: 3745-3757
[Abstract]
[Full Text]
-
Mascola, J. R., Lewis, M. G., VanCott, T. C., Stiegler, G., Katinger, H., Seaman, M., Beaudry, K., Barouch, D. H., Korioth-Schmitz, B., Krivulka, G., Sambor, A., Welcher, B., Douek, D. C., Montefiori, D. C., Shiver, J. W., Poignard, P., Burton, D. R., Letvin, N. L.
(2003). Cellular Immunity Elicited by Human Immunodeficiency Virus Type 1/ Simian Immunodeficiency Virus DNA Vaccination Does Not Augment the Sterile Protection Afforded by Passive Infusion of Neutralizing Antibodies. J. Virol.
77: 10348-10356
[Abstract]
[Full Text]
-
Srivastava, I. K., Liu, M. A.
(2003). Gene Vaccines. ANN INTERN MED
138: 550-559
[Abstract]
[Full Text]
-
Stevceva, L., Alvarez, X., Lackner, A. A., Tryniszewska, E., Kelsall, B., Nacsa, J., Tartaglia, J., Strober, W., Franchini, G.
(2002). Both Mucosal and Systemic Routes of Immunization with the Live, Attenuated NYVAC/Simian Immunodeficiency Virus SIVgpe Recombinant Vaccine Result in Gag-Specific CD8+ T-Cell Responses in Mucosal Tissues of Macaques. J. Virol.
76: 11659-11676
[Abstract]
[Full Text]
-
Horton, H., Vogel, T. U., Carter, D. K., Vielhuber, K., Fuller, D. H., Shipley, T., Fuller, J. T., Kunstman, K. J., Sutter, G., Montefiori, D. C., Erfle, V., Desrosiers, R. C., Wilson, N., Picker, L. J., Wolinsky, S. M., Wang, C., Allison, D. B., Watkins, D. I.
(2002). Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)-Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239. J. Virol.
76: 7187-7202
[Abstract]
[Full Text]
-
Crotty, S., Miller, C. J., Lohman, B. L., Neagu, M. R., Compton, L., Lu, D., Lu, F. X.-S., Fritts, L., Lifson, J. D., Andino, R.
(2001). Protection against Simian Immunodeficiency Virus Vaginal Challenge by Using Sabin Poliovirus Vectors. J. Virol.
75: 7435-7452
[Abstract]
[Full Text]
-
Guan, Y., Whitney, J. B., Detorio, M., Wainberg, M. A.
(2001). Construction and In Vitro Properties of a Series of Attenuated Simian Immunodeficiency Viruses with All Accessory Genes Deleted. J. Virol.
75: 4056-4067
[Abstract]
[Full Text]
-
Yovandich, J. L., Chertova, E. N., Kane, B. P., Gagliardi, T. D., Bess, J. W. Jr., Sowder, R. C. II, Henderson, L. E., Gorelick, R. J.
(2001). Alteration of Zinc-Binding Residues of Simian Immunodeficiency Virus p8NC Results in Subtle Differences in Gag Processing and Virion Maturation Associated with Degradative Loss of Mutant NC. J. Virol.
75: 115-124
[Abstract]
[Full Text]
-
Gorelick, R. J., Benveniste, R. E., Lifson, J. D., Yovandich, J. L., Morton, W. R., Kuller, L., Flynn, B. M., Fisher, B. A., Rossio, J. L., Piatak, M. Jr., Bess, J. W. Jr., Henderson, L. E., Arthur, L. O.
(2000). Protection of Macaca nemestrina from Disease following Pathogenic Simian Immunodeficiency Virus (SIV) Challenge: Utilization of SIV Nucleocapsid Mutant DNA Vaccines with and without an SIV Protein Boost. J. Virol.
74: 11935-11949
[Abstract]
[Full Text]